BeStock  
Stocks › Biotechnology › ACAD

ACADIA Pharmaceuticals ACAD

US equityMarket cap rank #2441Biotechnology
$17.11 −$0.48 (-2.73%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $17.12 +0.06%
Open$17.47
Prev close$17.59
Day range$17.05 – $17.79
Volume1.90M
Market cap$2.96B
P/E (TTM)8.1
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings8.8x
CheapRich

Around its usual level · 55th percentile, 5-year average -1.3x

#481 of 2993 stocks by PE (1 = cheapest)

Price / book2.3x
CheapRich

Near the bottom of its 5-year range · 0th percentile, 5-year average 6.2x

#3366 of 5330 stocks by PB (1 = cheapest)

Price / sales2.7x
CheapRich

Near the bottom of its 5-year range · 2nd percentile, 5-year average 4.9x

#2969 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-84x-23x39x100xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$22.86
Price vs. fair value-25.2%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 2.34 – 6.22 0% (cheaper than usual) #3366 of 5330 (1 = cheapest)
PE 8.84 18.98 -1.30 55% (pricier than usual) #481 of 2993 (1 = cheapest)
PS 2.70 2.22 4.93 2% (cheaper than usual) #2969 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ACAD.

Sign in to join the discussion.

Scroll to Top